ES2177545T3 - Metodo para purificar en gran medida seroalbumina humana. - Google Patents

Metodo para purificar en gran medida seroalbumina humana.

Info

Publication number
ES2177545T3
ES2177545T3 ES93916225T ES93916225T ES2177545T3 ES 2177545 T3 ES2177545 T3 ES 2177545T3 ES 93916225 T ES93916225 T ES 93916225T ES 93916225 T ES93916225 T ES 93916225T ES 2177545 T3 ES2177545 T3 ES 2177545T3
Authority
ES
Spain
Prior art keywords
hsa
vehicle
purify human
great measure
combined
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93916225T
Other languages
English (en)
Inventor
Naoto Fuluhata
Akinori Sumi
Takao Ohmura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tanabe Pharma Corp
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Application granted granted Critical
Publication of ES2177545T3 publication Critical patent/ES2177545T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE PREVE UN METODO PARA PURIFICAR ALTAMENTE ALBUMINA DE SUERO HUMANO (HSA) QUE CONSISTE EN LLEVAR UNA FRACCION QUE CONTIENE HSA PRODUCIDO POR MANIPULACION GENETICA EN CONTACTO CON UN VEHICULO DE CROMATOGRAFIA DE QUELATO QUE TIENE IONES DE COBRE COMBINADOS CON ESTE, Y ELUDIR EL HSA ABSORBIDO SOBRE EL VEHICULO USANDO UN TAMPON QUE TIENE UN PH DE 5 A 7 Y QUE CONTIENE CLORURO DE AMONIO COMO ANTAGONISTA. ESTE METODO PUEDE PREVER UN HSA ALTAMENTE PURO LIBRE DE COMPONENTE E ORIGEN DE LEVADURA QUE HAN SIDO DIFICILES DE ELIMINAR SATISFACTORIAMENTE POR EL METODO CONVENCIONAL DE PURIFICACION DE HSA PRODUCIDO POR MANIPULACION GENETICA.
ES93916225T 1992-07-31 1993-07-26 Metodo para purificar en gran medida seroalbumina humana. Expired - Lifetime ES2177545T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20563792A JP3360315B2 (ja) 1992-07-31 1992-07-31 ヒト血清アルブミンの高度精製方法

Publications (1)

Publication Number Publication Date
ES2177545T3 true ES2177545T3 (es) 2002-12-16

Family

ID=16510194

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93916225T Expired - Lifetime ES2177545T3 (es) 1992-07-31 1993-07-26 Metodo para purificar en gran medida seroalbumina humana.

Country Status (8)

Country Link
US (1) US5656729A (es)
EP (1) EP0656419B1 (es)
JP (1) JP3360315B2 (es)
CA (1) CA2141439C (es)
DE (1) DE69331992T2 (es)
DK (1) DK0656419T3 (es)
ES (1) ES2177545T3 (es)
WO (1) WO1994003626A1 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728553A (en) * 1992-09-23 1998-03-17 Delta Biotechnology Limited High purity albumin and method of producing
WO1997031947A1 (en) * 1996-02-29 1997-09-04 Delta Biotechnology Limited High purity albumin production process
US5994507A (en) * 1997-12-31 1999-11-30 Amersham Pharmacia Biotech Ab Method for binding albumin and means to be used in the method
US20030215359A1 (en) * 1998-10-02 2003-11-20 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US20050142613A1 (en) * 1998-10-02 2005-06-30 David Bar-Or Test for the rapid evaluation of ischemic states and kits
US6475743B1 (en) 1998-10-02 2002-11-05 Ischemia Technologies, Inc. Marker useful for detection and measurement of free radical damage and method
US7070937B1 (en) 1998-10-02 2006-07-04 Ischemia Technologies, Inc. Marker useful for detection and measurement of free radical damage and method
US7449338B2 (en) * 1998-10-02 2008-11-11 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US7282369B2 (en) * 1998-10-02 2007-10-16 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
GB9902000D0 (en) 1999-01-30 1999-03-17 Delta Biotechnology Ltd Process
SG173469A1 (en) 2009-02-20 2011-09-29 Ventria Bioscience Cell culture media containing combinations of proteins
US12629445B2 (en) 2020-03-20 2026-05-19 Bard Peripheral Vascular, Inc. Reactive hydrogel forming formulations and related methods, including methods of preparation
US12161777B2 (en) 2020-07-02 2024-12-10 Davol Inc. Flowable hemostatic suspension
US11739166B2 (en) 2020-07-02 2023-08-29 Davol Inc. Reactive polysaccharide-based hemostatic agent
WO2022146917A1 (en) 2020-12-28 2022-07-07 Davol Inc. Reactive dry powdered hemostatic materials comprising a protein and a multifunctionalized modified polyethylene glycol based crosslinking agent

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5562902A (en) * 1978-11-07 1980-05-12 Toray Ind Inc Separation of endotoxin
JPS59225121A (ja) * 1983-06-03 1984-12-18 Ajinomoto Co Inc インタ−ロイキン２の精製濃縮法
JPS6317898A (ja) * 1986-07-11 1988-01-25 Kyowa Hakko Kogyo Co Ltd リンホトキシン類の精製法
IL88326A (en) * 1987-11-18 1993-03-15 Gist Brocades Nv Purification of serum albumin
US5169936A (en) 1989-04-14 1992-12-08 Biogen, Inc. Protein purification on immobilized metal affinity resins effected by elution using a weak ligand
FR2648048B1 (fr) * 1989-06-08 1994-06-03 Lille Transfusion Sanguine Procede de preparation de solutions d'albumine purifiee
JPH03284692A (ja) * 1990-03-30 1991-12-16 Snow Brand Milk Prod Co Ltd ペプチド類の回収方法
US5330901A (en) * 1991-04-26 1994-07-19 Research Corporation Technologies, Inc. Expression of human serum albumin in Pichia pastoris
US5440018A (en) * 1992-05-20 1995-08-08 The Green Cross Corporation Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same

Also Published As

Publication number Publication date
EP0656419B1 (en) 2002-06-05
EP0656419A1 (en) 1995-06-07
JP3360315B2 (ja) 2002-12-24
DE69331992T2 (de) 2003-01-09
EP0656419A4 (en) 1996-05-29
CA2141439C (en) 2003-09-30
US5656729A (en) 1997-08-12
WO1994003626A1 (fr) 1994-02-17
CA2141439A1 (en) 1994-02-17
DK0656419T3 (da) 2002-09-30
JPH0646873A (ja) 1994-02-22
DE69331992D1 (de) 2002-07-11

Similar Documents

Publication Publication Date Title
BR9603809A (pt) Composto composição orgânica estável e processo de melhoramento da atividade estabilizadora de um antidergradante
ES539772A0 (es) Perfeccionamientos en los sistemas de vaporizar agentes ter-micamente vaporizables
NO933882D0 (no) Kjoeretoey for godshaandtering
BR9405811A (pt) Novos agentes antiparasíticos relacionados com as milbemicinas e com as avermectinas
ES2111710T3 (es) Proteasas que inhiben y desprenden el biofilm.
WO1996020688A3 (en) Triggered pore-forming agents
CA2149776A1 (en) Use of methioninase as an antitumor agent in anti-methionine chemotherapy
ITMI941891A0 (it) 3-aril-benzofuranoni come agenti stabilizzanti
PT1135163E (pt) Composicao topicas contendo ascomicinas
EP0293684A3 (en) Use of organosilicium modified polydienes as antifoaming and antibubble agents in organic systems
BR8704478A (pt) Composicao adequada para inibir a corrosao de um metal a base de ferro em contato com a agua de sistema de um sistema aquoso,e processo para inibir a corrosao de um metal a base de ferro em contato com a agua de sistema de um sistema de um sistema aguoso
BR8506460A (pt) Conjunto de valvula de gatilho em linha
BR8406489A (pt) Conjunto de orientadores de condutor para plataforma de poco offshore e processo para montar o mesmo
FI935356A7 (fi) Menetelmä vetyperoksidin vesiliuosten hiilipitoisuuden vähentämiseksi
SV1994000064A (es) Derivados de acidos 1-(2-fluorciclopropil)-quinolon-naftiridon carboxilicos, ref.le a 29 869-sv.
DE69326907D1 (de) Wasserstoff absorbierende Legierung für negative Elektrode
KR860003337A (ko) B형간염 항원의 정제방법
DE3481814D1 (de) Kosmetikum.
LV10825A (lv) Rudzu homozigoto liniju iegusanas panemiens
AT383825B (de) Adsorptionsmittel
BR8600328A (pt) Composicao inseticida que libera seletivamente os compostos ativos nela presentes
ES542248A0 (es) Procedimiento para el aprovechamiento de yacimientos de me- tal con baja concentracion
AR002397A1 (es) Un metodo para tratar agua con peroxido de hidrogeno y un estabilizador de amonio policuaternario.
IT1219303B (it) Acceleratore particolarmente per veicoli industriali
BR8008515A (pt) Assento aperfeicoado de morteiro em veiculo